Journal of Leukocyte Biology, Vol 67, Issue 4 559-566, Copyright © 2000 by Society for Leukocyte Biology
JOURNAL ARTICLE |
F Chen, J Rao and GP Studzinski
Department of Pathology & Laboratory Medicine, UMD-New Jersey Medical School, Newark 07103-2714, USA.
Hematopoietic cell differentiation takes place in phenotypically recognizable stages characterized by morphology as well as by the expression of enzymes and surface markers. It is recognized that differentiation results from an interaction of environmental cues, such as cytokines and hormones, with internal cellular programs, but the precise mechanisms are not entirely clear. HL60 cells, a human acute myeloid leukemia (AML) cell line with promyelocytic features, provide a model for such studies because they behave like stem cells, which can differentiate into two different lineages, granulocytic or monocytic/macrophage, depending on the inducer. Protein levels and kinase activity of cyclin-dependent kinase 5 (Cdk5) were reported [F. Chen and G. P. Studzinski (1999) Exp. Cell Res. 249, 422, 1999] to increase in HL60 cells induced to monocytic differentiation by 1alpha,25-dihydroxyvitamin D3 (1,25D3), but the specificity of the association of Cdk5 with the monocytic phenotype has not been established. We show here that up-regulation of Cdk5 does not occur in granulocytic differentiation, whereas inhibition of Cdk5 activity by olomoucine, or its expression by a plasmid construct expressing antisense Cdk5, switches the 1,25D3-induced monocytic phenotype (a combination of positive nonspecific esterase reaction, expression of the CD14 marker, and morphology) to general myeloid phenotype (positive nitro-blue tetrazolium reaction, CD11b marker and morphology). The transcriptional up-regulation of Cdk5 by 1,25D3 was not inhibited by olomoucine. These findings show that in human myeloid cells up-regulation of Cdk5 is specifically associated with the monocytic phenotype.
This article has been cited by other articles:
 |
|
 |
|
  M. Danilenko, Q. Wang, X. Wang, J. Levy, Y. Sharoni, and G. P. Studzinski Carnosic Acid Potentiates the Antioxidant and Prodifferentiation Effects of 1{alpha},25-Dihydroxyvitamin D3 in Leukemia Cells but Does Not Promote Elevation of Basal Levels of Intracellular Calcium Cancer Res., March 15, 2003; 63(6): 1325 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gao, S. Negash, H. T. Guo, D. Ledee, H.-S. Wang, and P. Zelenka CDK5 Regulates Cell Adhesion and Migration in Corneal Epithelial Cells Mol. Cancer Res., November 1, 2002; 1(1): 12 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Negash, H.-S. Wang, C. Gao, D. Ledee, and P. Zelenka Cdk5 regulates cell-matrix and cell-cell adhesion in lens epithelial cells J. Cell Sci., May 15, 2002; 115(10): 2109 - 2117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Danilenko, X. Wang, and G. P. Studzinski Carnosic Acid and Promotion of Monocytic Differentiation of HL60-G Cells Initiated by Other Agents J Natl Cancer Inst, August 15, 2001; 93(16): 1224 - 1233. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chen and G. P. Studzinski Expression of the neuronal cyclin-dependent kinase 5 activator p35Nck5a in human monocytic cells is associated with differentiation Blood, June 15, 2001; 97(12): 3763 - 3767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catania, S. Urban, E. Yan, C. Hao, G. Barron, and J. Allalunis-Turner Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells Neuro-oncol, April 1, 2001; 3(2): 89 - 98. [Abstract] [PDF]
|
|
|
|
|
|
C Gao, S Negash, H. Wang, D Ledee, H Guo, P Russell, and P Zelenka Cdk5 mediates changes in morphology and promotes apoptosis of astrocytoma cells in response to heat shock J. Cell Sci., January 3, 2001; 114(6): 1145 - 1153. [Abstract] [PDF]
|
|
